| Old Articles: <Older 3201-3210 Newer> |
|---|
 |
Food Processing
August 2012
David TerMolen |
Nutella Lawsuit Highlights Marketing Risks Class action settlement a warning to processors touting 'healthy' products.   |
Chemistry World
August 2, 2012 |
Monsanto wins $1bn in patent case A US court has awarded $1 billion in damages to Monsanto following a patent dispute with DuPont over crops bred to be resistant to the popular pesticide glyphosphate. |
CFO
August 1, 2012
Randy Myers |
Unfinished Business Two years after the passage of the Dodd-Frank Act, the law's implementation is far behind schedule, and its success is still in doubt. |
CFO
August 1, 2012
Edward Teach |
Dodd-Frank at Two Overhauling the world's largest financial system doesn't happen overnight. |
CFO
August 1, 2012
Vincent Ryan |
High Court Upholds Health-Care Reform The Supreme Court's ruling leaves companies with decisions to make. |
On Wall Street
August 1, 2012
Alan J. Foxman |
FINRA's New Suitability Rule I'm a compliance officer for a small brokerage firm. I'm a little confused by FINRA's new suitability rule. What, if anything, extra does it require us to do? |
Information Today
July 30, 2012
George H. Pike |
Justice Department Responds to Ebook Lawsuit Objections The U.S. Department of Justice responded to public comments made objecting to the department's proposed settlement of price fixing charges levied against Apple, Inc., HarperCollins, Simon & Schuster, and four other publishers. |
Chemistry World
July 6, 2012
Andrew Turley |
Brazil hits BASF with worker payout The case relates to a pesticides plant in Paulinia, Brazil, which BASF says in its 2011 annual report was 'significantly contaminated by the production of crop protection products'. |
On Wall Street
July 1, 2012
Alan J. Foxman |
Defining Full Disclosure Legal questions are answered on disclosure of civil actions and bankruptcy for registered investment adviser applicants and which members of an RIA firm may have control of an LLC. |
Chemistry World
June 20, 2012 |
Nasonex patent ruling goes against Merck & Co The US court ruled that, although the Merck patent in question was valid, it should not stop Canadian generics company Apotex marketing its mometasone furoate product. |
| <Older 3201-3210 Newer> Return to current articles. |
